|
Atomistry » Chlorine » PDB 4i22-4ibe » 4i22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 4i22-4ibe » 4i22 » |
Chlorine in PDB 4i22: Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with GefitinibEnzymatic activity of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib
All present enzymatic activity of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib:
2.7.10.1; Protein crystallography data
The structure of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib, PDB code: 4i22
was solved by
K.S.Gajiwala,
J.Feng,
R.Ferre,
K.Ryan,
O.Brodsky,
A.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4i22:
The structure of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib
(pdb code 4i22). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib, PDB code: 4i22: Chlorine binding site 1 out of 1 in 4i22Go back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib
![]() Mono view ![]() Stereo pair view
Reference:
K.S.Gajiwala,
J.Feng,
R.Ferre,
K.Ryan,
O.Brodsky,
S.Weinrich,
J.C.Kath,
A.Stewart.
Insights Into the Aberrant Activity of Mutant Egfr Kinase Domain and Drug Recognition. Structure V. 21 209 2013.
Page generated: Fri Jul 11 16:39:44 2025
ISSN: ISSN 0969-2126 PubMed: 23273428 DOI: 10.1016/J.STR.2012.11.014 |
Last articlesMg in 7DWQMg in 7E0G Mg in 7E03 Mg in 7DZ6 Mg in 7DZ5 Mg in 7DZ4 Mg in 7DZ3 Mg in 7DZ2 Mg in 7DYK Mg in 7DXH |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |